DURVALUMAB

DURVALUMAB was reported 21581 times

DURVALUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPITHELITIS 16 0.7619
1 RADIATION PNEUMONITIS 812 0.3791
2 OESOPHAGOMEDIASTINAL FISTULA 7 0.3500
3 DIFFUSE UVEAL MELANOCYTIC PROLIFERATION 6 0.3158
4 BILE DUCT CANCER RECURRENT 7 0.2500
5 NON-SMALL CELL LUNG CANCER RECURRENT 64 0.2261
6 IMMUNOTOXICITY 22 0.1930
7 PULMONARY RADIATION INJURY 11 0.1803
8 TUMOUR HYPERPROGRESSION 36 0.1452
9 LUNG SQUAMOUS CELL CARCINOMA RECURRENT 6 0.1395
10 ARTERIAL INTRAMURAL HAEMATOMA 11 0.1375
11 RADIATION INTERACTION 11 0.1325
12 LIVER CARCINOMA RUPTURED 33 0.1310
13 BILIARY TRACT INFECTION 75 0.1206
14 ENDOCRINE TOXICITY 12 0.1176
15 IMMUNE-MEDIATED NEPHRITIS 55 0.1173
16 SMALL CELL LUNG CANCER RECURRENT 6 0.1053
17 SICCA SYNDROME 20 0.1036
18 PROTEIN INDUCED BY VITAMIN K ABSENCE OR ANTAGONIST II INCREASED 7 0.0959
19 MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME 21 0.0921
20 CHOLANGITIS INFECTIVE 24 0.0902
21 PARANEOPLASTIC NEUROLOGICAL SYNDROME 11 0.0859
22 IMMUNE-MEDIATED PNEUMONITIS 19 0.0812
23 IMMUNE-MEDIATED HEPATIC DISORDER 150 0.0768
24 THYROXINE FREE ABNORMAL 6 0.0750
25 GALLBLADDER ADENOCARCINOMA 5 0.0704
26 IMMUNE-MEDIATED LUNG DISEASE 128 0.0701
27 IMMUNE-MEDIATED MYOCARDITIS 113 0.0699
28 ENDOMETRIAL CANCER RECURRENT 9 0.0687
29 RADIATION OESOPHAGITIS 26 0.0682
30 BACTERIAL ABDOMINAL INFECTION 10 0.0680
31 LUNG ADENOCARCINOMA RECURRENT 7 0.0680
32 THROMBOPHLEBITIS MIGRANS 23 0.0676
33 IMMUNE-MEDIATED ENTEROCOLITIS 238 0.0647
34 IMMUNE-MEDIATED HEPATITIS 131 0.0641
35 IMMUNE-MEDIATED CHOLANGITIS 23 0.0641
36 IMMUNE-MEDIATED DERMATITIS 64 0.0635
37 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 74 0.0594
38 IMMUNE-MEDIATED MYASTHENIA GRAVIS 19 0.0585
39 SILENT THYROIDITIS 8 0.0556
40 BRONCHIAL FISTULA 11 0.0545
41 AUTOIMMUNE NEPHRITIS 11 0.0500
42 SUSPECTED DRUG-INDUCED LIVER INJURY 10 0.0500
43 IMMUNE-MEDIATED PANCREATITIS 18 0.0472
44 IMMUNE-MEDIATED RENAL DISORDER 19 0.0459
45 METASTASES TO ADRENALS 42 0.0455
46 IMMUNE-MEDIATED ENCEPHALITIS 24 0.0454
47 CHOLANGITIS 263 0.0424
48 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 37 0.0421
49 AUTOIMMUNE HYPOTHYROIDISM 10 0.0420
50 LYMPHOMA TRANSFORMATION 15 0.0417
51 OROPHARYNGEAL OEDEMA 6 0.0414
52 IMMUNE-MEDIATED HYPOTHYROIDISM 45 0.0399
53 DYSBIOSIS 32 0.0390
54 IMMUNE-MEDIATED THYROIDITIS 19 0.0385
55 IMMUNE-MEDIATED HYPOPHYSITIS 17 0.0377
56 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 30 0.0376
57 IMMUNE-MEDIATED ADVERSE REACTION 57 0.0371
58 IMMUNE-MEDIATED ARTHRITIS 14 0.0367
59 HYPOPHYSITIS 73 0.0363
60 PNEUMONITIS 900 0.0330
61 POROKERATOSIS 6 0.0326
62 IMMUNE-MEDIATED HYPERTHYROIDISM 8 0.0315
63 ENTEROCOLITIS INFECTIOUS 29 0.0314
64 FULMINANT TYPE 1 DIABETES MELLITUS 32 0.0310
65 CHOLANGIOCARCINOMA 45 0.0302
66 BILIARY OBSTRUCTION 39 0.0301
67 DYSDIADOCHOKINESIS 5 0.0292
68 LYMPHOCYTIC HYPOPHYSITIS 8 0.0290
69 THYROIDITIS 87 0.0289
70 INTESTINAL METASTASIS 10 0.0275
71 METASTASES TO CENTRAL NERVOUS SYSTEM 352 0.0273
72 CHOLANGITIS ACUTE 20 0.0265
73 BILE DUCT STENOSIS 31 0.0259
74 TUMOUR PERFORATION 8 0.0252
75 HYPOPITUITARISM 43 0.0247
76 INFECTED NEOPLASM 6 0.0241
77 MYOCARDITIS 274 0.0239
78 ALPHA 1 FOETOPROTEIN INCREASED 17 0.0239
79 HYPERCREATININAEMIA 12 0.0239
80 ENCEPHALITIS AUTOIMMUNE 31 0.0236
81 PULMONARY NECROSIS 8 0.0235
82 ENDOCRINE DISORDER 30 0.0234
83 DUODENAL OBSTRUCTION 7 0.0233
84 SUPERIOR VENA CAVA SYNDROME 14 0.0232
85 TUMOUR RUPTURE 13 0.0231
86 IMMUNE-MEDIATED MYOSITIS 61 0.0221
87 HEPATIC INFECTION 28 0.0219
88 NEPHRITIS 69 0.0206
89 LIVER ABSCESS 67 0.0206
90 AUTOIMMUNE COLITIS 13 0.0202
91 PULMONARY TOXICITY 141 0.0199
92 LICHENOID KERATOSIS 45 0.0197
93 HYPERLIPASAEMIA 10 0.0191
94 AUTOIMMUNE MYOSITIS 9 0.0191
95 BACILLUS INFECTION 12 0.0190
96 SMALL CELL LUNG CANCER 28 0.0185
97 HYPOTHALAMO-PITUITARY DISORDER 26 0.0178
98 ADRENAL DISORDER 34 0.0177
99 CARBUNCLE 5 0.0177
100 METASTASES TO PLEURA 18 0.0172
101 MYOSITIS 151 0.0168
102 MALIGNANT NEOPLASM PROGRESSION 1703 0.0166
103 DUODENAL STENOSIS 8 0.0165
104 BLOOD CORTICOTROPHIN DECREASED 8 0.0164
105 ADRENAL INSUFFICIENCY 196 0.0161
106 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 10 0.0161
107 BRONCHOPLEURAL FISTULA 6 0.0160
108 METASTASES TO PANCREAS 7 0.0158
109 MALIGNANT TRANSFORMATION 7 0.0156
110 TUMOUR PSEUDOPROGRESSION 17 0.0155
111 IMMUNE THROMBOCYTOPENIA 70 0.0153
112 HAEMOBILIA 6 0.0145
113 EOSINOPHILIC FASCIITIS 5 0.0144
114 ENTEROCOLITIS 83 0.0144
115 CAUDA EQUINA SYNDROME 11 0.0143
116 MYASTHENIA GRAVIS 114 0.0141
117 CHOROIDITIS 5 0.0134
118 CYTOKINE STORM 9 0.0131
119 GASTROINTESTINAL TOXICITY 61 0.0127
120 BILE DUCT CANCER 15 0.0126
121 METASTASES TO SKIN 13 0.0126
122 MYOCARDIAL NECROSIS MARKER INCREASED 21 0.0125
123 LYMPHANGIOSIS CARCINOMATOSA 13 0.0125
124 INFECTIOUS PLEURAL EFFUSION 19 0.0125
125 CORTISOL DECREASED 14 0.0122
126 EVANS SYNDROME 6 0.0122
127 LUNG OPACITY 32 0.0121
128 TYPE 1 DIABETES MELLITUS 72 0.0119
129 AUTOIMMUNE PANCREATITIS 6 0.0119
130 GLUCOCORTICOID DEFICIENCY 5 0.0118
131 CREATINE KINASE INCREASED 9 0.0117
132 CYTOKINE RELEASE SYNDROME 235 0.0117
133 CHOLANGITIS SCLEROSING 24 0.0117
134 MYASTHENIC SYNDROME 9 0.0116
135 METASTASES TO PERITONEUM 29 0.0115
136 MYELITIS TRANSVERSE 16 0.0113
137 CARBOHYDRATE ANTIGEN 19-9 INCREASED 6 0.0113
138 HEPATOBILIARY DISEASE 7 0.0112
139 ENCEPHALITIS 76 0.0110
140 NON-SMALL CELL LUNG CANCER 52 0.0108
141 HYPERTHYROIDISM 156 0.0108
142 MALIGNANT PLEURAL EFFUSION 18 0.0107
143 METASTASES TO LYMPH NODES 72 0.0107
144 HAEMATOTOXICITY 101 0.0106
145 COLITIS 400 0.0105
146 HYPERSENSITIVITY PNEUMONITIS 12 0.0105
147 PARANEOPLASTIC SYNDROME 7 0.0104
148 CARCINOEMBRYONIC ANTIGEN INCREASED 20 0.0103
149 NEUTROPHIL COUNT DECREASED 420 0.0103
150 CRITICAL ILLNESS 8 0.0103
151 PANCREATIC ENZYMES INCREASED 15 0.0102
152 INTERSTITIAL LUNG DISEASE 491 0.0101
153 NEUROENDOCRINE CARCINOMA 7 0.0101
154 HYPOTHYROIDISM 322 0.0101
155 MYELOSUPPRESSION 363 0.0101
156 RHEUMATIC DISORDER 19 0.0098
157 GALLBLADDER CANCER 14 0.0095
158 APLASIA PURE RED CELL 32 0.0093
159 METASTASIS 66 0.0092
160 METASTASES TO MENINGES 21 0.0092
161 MALIGNANT ASCITES 7 0.0091
162 PULMONARY ARTERY THROMBOSIS 7 0.0091
163 CYTOMEGALOVIRUS ENTEROCOLITIS 7 0.0091
164 HILAR LYMPHADENOPATHY 8 0.0091
165 SARS-COV-2 TEST NEGATIVE 6 0.0089
166 ORGANISING PNEUMONIA 44 0.0089
167 PLEURAL THICKENING 6 0.0088
168 ENANTHEMA 5 0.0087
169 OESOPHAGITIS 94 0.0086
170 SKIN TOXICITY 48 0.0085
171 METASTASES TO LIVER 149 0.0085
172 TUMOUR HAEMORRHAGE 24 0.0084
173 DERMATITIS PSORIASIFORM 17 0.0083
174 SYSTEMIC SCLERODERMA 6 0.0082
175 METASTASES TO LUNG 94 0.0081
176 LUNG ABSCESS 17 0.0081
177 URINARY TRACT OBSTRUCTION 19 0.0080
178 BRAIN STEM SYNDROME 6 0.0080
179 MYOCARDIAL INJURY 9 0.0080
180 RENAL COLIC 18 0.0080
181 CORNEAL PERFORATION 5 0.0079
182 HYPERLEUKOCYTOSIS 7 0.0079
183 METASTASES TO BONE 129 0.0079
184 METASTATIC MALIGNANT MELANOMA 18 0.0078
185 PORTAL VEIN THROMBOSIS 25 0.0077
186 HEPATITIS 197 0.0077
187 PEMPHIGOID 58 0.0077
188 BRONCHIAL CARCINOMA 6 0.0076
189 VASCULAR PSEUDOANEURYSM 13 0.0075
190 JAUNDICE CHOLESTATIC 26 0.0074
191 SIALOADENITIS 10 0.0073
192 AUTOIMMUNE HAEMOLYTIC ANAEMIA 25 0.0073
193 GUILLAIN-BARRE SYNDROME 35 0.0072
194 BILIARY TRACT DISORDER 10 0.0072
195 OESOPHAGEAL PERFORATION 6 0.0072
196 ADRENOCORTICAL INSUFFICIENCY ACUTE 14 0.0072
197 LUNG CONSOLIDATION 20 0.0071
198 HAEMOPHILUS INFECTION 7 0.0071
199 HEPATIC CYTOLYSIS 91 0.0071
200 ENDOCRINE OPHTHALMOPATHY 6 0.0069
201 ACQUIRED GENE MUTATION 9 0.0069
202 METASTASES TO SPINE 23 0.0068
203 NON-SMALL CELL LUNG CANCER METASTATIC 6 0.0068
204 VITILIGO 16 0.0068
205 ACUTE PROMYELOCYTIC LEUKAEMIA 7 0.0068
206 DEMYELINATING POLYNEUROPATHY 7 0.0068
207 BILIARY DILATATION 10 0.0068
208 TROPONIN INCREASED 51 0.0067
209 HEPATORENAL SYNDROME 11 0.0065
210 ADENOCARCINOMA GASTRIC 6 0.0065
211 MYELITIS 10 0.0065
212 HEPATIC FUNCTION ABNORMAL 236 0.0063
213 PNEUMONIA BACTERIAL 58 0.0063
214 POSTOPERATIVE WOUND COMPLICATION 8 0.0063
215 ENTERITIS 40 0.0062
216 PHYSICAL DECONDITIONING 16 0.0062
217 CYTOPENIA 76 0.0062
218 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 11 0.0062
219 PULMONARY TUBERCULOSIS 26 0.0061
220 MUCOSAL DISORDER 6 0.0060
221 POLYMYALGIA RHEUMATICA 19 0.0060
222 SECONDARY ADRENOCORTICAL INSUFFICIENCY 9 0.0060
223 OTOTOXICITY 11 0.0059
224 SMALL INTESTINAL PERFORATION 11 0.0059
225 POLYNEUROPATHY 70 0.0058
226 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
227 VASCULAR PURPURA 8 0.0057
228 POLYARTHRITIS 30 0.0057
229 TUMOUR NECROSIS 6 0.0057
230 PRERENAL FAILURE 8 0.0057
231 PERIPHERAL SENSORY NEUROPATHY 33 0.0056
232 RADIATION INJURY 6 0.0056
233 NEUROMYOPATHY 6 0.0056
234 TUMOUR MARKER INCREASED 27 0.0056
235 PNEUMONIA LEGIONELLA 9 0.0056
236 PNEUMOTHORAX 89 0.0056
237 AUTOIMMUNE HEPATITIS 39 0.0056
238 HENOCH-SCHONLEIN PURPURA 12 0.0055
239 CHOLESTATIC LIVER INJURY 12 0.0054
240 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 6 0.0053
241 LIVER DISORDER 237 0.0053
242 TUMOUR PAIN 7 0.0053
243 THYROTOXIC CRISIS 6 0.0053
244 ARTERIAL HAEMORRHAGE 6 0.0052
245 CLOSTRIDIUM DIFFICILE COLITIS 55 0.0052
246 EMBOLISM 43 0.0052
247 RADIATION SKIN INJURY 6 0.0052
248 FEBRILE BONE MARROW APLASIA 22 0.0052
249 EXTREMITY NECROSIS 9 0.0052
250 BICYTOPENIA 10 0.0051
251 DEVICE RELATED THROMBOSIS 5 0.0051
252 GASTROINTESTINAL PERFORATION 21 0.0050
253 CULTURE URINE POSITIVE 7 0.0050
254 CHRONIC RESPIRATORY FAILURE 6 0.0050
255 AUTONOMIC NEUROPATHY 5 0.0049
256 RADICULOPATHY 13 0.0049
257 THYROID DISORDER 75 0.0049
258 DEATH 4160 0.0048
259 HEPATIC ENCEPHALOPATHY 45 0.0048
260 FEBRILE NEUTROPENIA 316 0.0048
261 LICHEN PLANUS 11 0.0047
262 LYMPHADENOPATHY MEDIASTINAL 9 0.0047
263 HEPATIC MASS 9 0.0047
264 RECURRENT CANCER 19 0.0047
265 CUTANEOUS VASCULITIS 17 0.0047
266 GALLBLADDER ENLARGEMENT 5 0.0046
267 STRESS CARDIOMYOPATHY 27 0.0046
268 CUTANEOUS LUPUS ERYTHEMATOSUS 9 0.0046
269 RENAL TUBULAR DISORDER 13 0.0046
270 IMMUNE THROMBOCYTOPENIC PURPURA 13 0.0046
271 CELL DEATH 9 0.0045
272 POLYMYOSITIS 8 0.0045
273 HAEMATOLOGICAL INFECTION 11 0.0045
274 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0045
275 MONOPARESIS 8 0.0044
276 METASTATIC NEOPLASM 19 0.0044
277 BLOOD THYROID STIMULATING HORMONE DECREASED 20 0.0044
278 HEPATOCELLULAR CARCINOMA 33 0.0043
279 AMYLASE INCREASED 16 0.0043
280 CANCER PAIN 11 0.0043
281 BLOOD CREATINE INCREASED 19 0.0043
282 DRUG-INDUCED LIVER INJURY 133 0.0042
283 HYPERPHOSPHATAEMIA 9 0.0042
284 INFECTED CYST 5 0.0042
285 CARDIAC DEATH 5 0.0041
286 PERFORMANCE STATUS DECREASED 19 0.0041
287 MULTI-ORGAN DISORDER 8 0.0041
288 PLEURISY 24 0.0040
289 EMPYEMA 8 0.0040
290 PLEURAL EFFUSION 244 0.0040
291 LUNG DISORDER 196 0.0040
292 MULTIPLE ORGAN DYSFUNCTION SYNDROME 113 0.0040
293 KERATITIS 12 0.0039
294 LIPASE INCREASED 30 0.0039
295 ABDOMINAL INFECTION 10 0.0039
296 CEREBRAL INFARCTION 95 0.0039
297 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
298 ASCITES 113 0.0038
299 AZOTAEMIA 15 0.0038
300 KETOACIDOSIS 28 0.0037
301 HYPOPROTEINAEMIA 7 0.0037
302 THROMBOTIC THROMBOCYTOPENIC PURPURA 13 0.0037
303 OESOPHAGEAL VARICES HAEMORRHAGE 8 0.0037
304 INTESTINAL PERFORATION 41 0.0036
305 EXTRAVASATION 15 0.0036
306 TUBULOINTERSTITIAL NEPHRITIS 68 0.0036
307 CARDIAC TAMPONADE 17 0.0036
308 NEOPLASM PROGRESSION 124 0.0036
309 PULMONARY ALVEOLAR HAEMORRHAGE 20 0.0036
310 DERMATOMYOSITIS 9 0.0035
311 ERYTHEMA MULTIFORME 33 0.0035
312 DERMATITIS 74 0.0035
313 TUMOUR LYSIS SYNDROME 31 0.0035
314 HAEMOLYTIC URAEMIC SYNDROME 8 0.0034
315 ATRIOVENTRICULAR BLOCK COMPLETE 23 0.0034
316 PLATELET COUNT DECREASED 366 0.0034
317 THROMBOCYTOPENIA 383 0.0034
318 VENOUS THROMBOSIS LIMB 7 0.0034
319 JAUNDICE 89 0.0033
320 CHOLESTASIS 62 0.0032
321 UPPER GASTROINTESTINAL HAEMORRHAGE 54 0.0032
322 CHOLECYSTITIS 38 0.0032
323 INTERVERTEBRAL DISCITIS 6 0.0032
324 CEREBRAL THROMBOSIS 9 0.0032
325 OXYGEN SATURATION ABNORMAL 9 0.0032
326 DISEASE PROGRESSION 375 0.0032
327 HICCUPS 26 0.0032
328 ADENOCARCINOMA 7 0.0031
329 SUSPECTED OFF LABEL USE 14 0.0031
330 HYPOALBUMINAEMIA 24 0.0031
331 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 23 0.0031
332 LOCALISED OEDEMA 14 0.0030
333 BLOOD DISORDER 24 0.0030
334 POTENTIATING DRUG INTERACTION 10 0.0030
335 NEOPLASM RECURRENCE 10 0.0029
336 FACIAL PARALYSIS 25 0.0029
337 PERICARDIAL EFFUSION 67 0.0029
338 LIVER FUNCTION TEST INCREASED 61 0.0028
339 BILE DUCT STONE 9 0.0028
340 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 29 0.0028
341 HEPATIC FAILURE 85 0.0028
342 OESOPHAGEAL STENOSIS 8 0.0028
343 CARDIOTOXICITY 25 0.0028
344 APPENDICITIS 26 0.0028
345 LUNG CANCER METASTATIC 8 0.0028
346 THROMBOTIC MICROANGIOPATHY 27 0.0028
347 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
348 HAEMOPTYSIS 77 0.0028
349 SKIN DISORDER 92 0.0028
350 BLOOD BILIRUBIN INCREASED 74 0.0027
351 HYPERTRANSAMINASAEMIA 19 0.0027
352 BACTERAEMIA 32 0.0027
353 AGRANULOCYTOSIS 50 0.0027
354 LARGE INTESTINAL OBSTRUCTION 6 0.0027
355 SMALL INTESTINAL OBSTRUCTION 33 0.0027
356 NEPHROPATHY TOXIC 30 0.0027
357 NEUTROPENIC SEPSIS 19 0.0027
358 LUNG ADENOCARCINOMA 8 0.0027
359 EYELID PTOSIS 27 0.0027
360 THYROID FUNCTION TEST ABNORMAL 11 0.0026
361 BLOOD THYROID STIMULATING HORMONE INCREASED 24 0.0026
362 DUODENITIS 8 0.0026
363 DRUG ERUPTION 46 0.0026
364 OPTIC ISCHAEMIC NEUROPATHY 10 0.0026
365 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
366 LEUKOPENIA 129 0.0026
367 GASTRIC PERFORATION 7 0.0026
368 PULMONARY HAEMORRHAGE 20 0.0026
369 ACUTE CORONARY SYNDROME 21 0.0025
370 HYPERBILIRUBINAEMIA 26 0.0025
371 ANAEMIA 477 0.0025
372 ILEUS 31 0.0025
373 LYMPHADENITIS 6 0.0025
374 NEUTROPHIL COUNT ABNORMAL 7 0.0025
375 SEPTIC SHOCK 107 0.0025
376 LARGE INTESTINE PERFORATION 17 0.0024
377 IMMUNE SYSTEM DISORDER 32 0.0024
378 RESPIRATORY FAILURE 176 0.0024
379 PULMONARY PAIN 7 0.0024
380 NEUTROPENIA 323 0.0024
381 KLEBSIELLA INFECTION 12 0.0024
382 COVID-19 PNEUMONIA 28 0.0024
383 CARDIOMYOPATHY 35 0.0024
384 SUDDEN DEATH 25 0.0024
385 DIABETIC KETOACIDOSIS 56 0.0023
386 MIXED LIVER INJURY 7 0.0023
387 BONE MARROW DISORDER 7 0.0023
388 CHOLECYSTITIS ACUTE 13 0.0023
389 ASPERGILLUS INFECTION 15 0.0023
390 HUMERUS FRACTURE 11 0.0023
391 ATELECTASIS 22 0.0023
392 ENDOMETRIAL CANCER 5 0.0023
393 LUNG INFILTRATION 20 0.0023
394 PROTEINURIA 43 0.0023
395 GAMMA-GLUTAMYLTRANSFERASE INCREASED 50 0.0023
396 PANCYTOPENIA 126 0.0023
397 THERAPY PARTIAL RESPONDER 35 0.0022
398 ILEUS PARALYTIC 10 0.0022
399 MENINGITIS ASEPTIC 10 0.0022
400 PERIPHERAL ISCHAEMIA 9 0.0022
401 ORAL FUNGAL INFECTION 6 0.0022
402 DISEASE COMPLICATION 10 0.0022
403 NEUROPATHY PERIPHERAL 207 0.0022
404 NEOPLASM 25 0.0022
405 ASPARTATE AMINOTRANSFERASE INCREASED 115 0.0022
406 HEPATIC NEOPLASM 7 0.0021
407 PROCTITIS 6 0.0021
408 CEREBRAL ISCHAEMIA 11 0.0021
409 BRAIN OEDEMA 27 0.0021
410 AUTOIMMUNE THYROIDITIS 8 0.0021
411 RASH MACULO-PAPULAR 47 0.0021
412 PNEUMATOSIS INTESTINALIS 6 0.0021
413 CARDIAC FAILURE ACUTE 14 0.0021
414 MENINGITIS 14 0.0021
415 THYROID MASS 8 0.0021
416 MYOPATHY 18 0.0021
417 PULMONARY MASS 31 0.0021
418 SEPSIS 232 0.0021
419 TRANSAMINASES INCREASED 46 0.0021
420 GASTROINTESTINAL NECROSIS 6 0.0021
421 COMPRESSION FRACTURE 11 0.0021
422 ALANINE AMINOTRANSFERASE INCREASED 126 0.0021
423 NEPHROTIC SYNDROME 14 0.0020
424 PANCREATIC DISORDER 10 0.0020
425 BLOOD CREATINE PHOSPHOKINASE INCREASED 58 0.0020
426 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
427 HAEMOLYTIC ANAEMIA 18 0.0020
428 BLOOD CULTURE POSITIVE 6 0.0020
429 CREATININE RENAL CLEARANCE DECREASED 8 0.0020
430 HEPATITIS B 12 0.0020
431 HYPOXIA 70 0.0020
432 NECROTISING FASCIITIS 7 0.0020
433 VARICES OESOPHAGEAL 6 0.0020
434 ACUTE RESPIRATORY FAILURE 38 0.0020
435 PERICARDITIS 33 0.0020
436 BRAIN NEOPLASM 18 0.0020
437 IMMUNODEFICIENCY 29 0.0019
438 CACHEXIA 10 0.0019
439 PYREXIA 670 0.0019
440 SPONDYLITIS 7 0.0019
441 HEPATIC CIRRHOSIS 36 0.0019
442 APLASTIC ANAEMIA 10 0.0019
443 EOSINOPHILIC PNEUMONIA 6 0.0019
444 GENERAL PHYSICAL HEALTH DETERIORATION 220 0.0019
445 SARCOIDOSIS 9 0.0019
446 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 18 0.0019
447 CARDIAC DYSFUNCTION 7 0.0019
448 BLOOD POTASSIUM ABNORMAL 5 0.0019
449 HEPATIC PAIN 8 0.0019
450 FEEDING DISORDER 38 0.0019
451 LUNG NEOPLASM 8 0.0019
452 PANCREATITIS ACUTE 42 0.0019
453 HEPATIC LESION 8 0.0018
454 STEVENS-JOHNSON SYNDROME 41 0.0018
455 HEPATOTOXICITY 41 0.0018
456 HYPERGLYCAEMIA 67 0.0018
457 ENCEPHALOPATHY 45 0.0018
458 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
459 INTESTINAL ISCHAEMIA 10 0.0018
460 ABDOMINAL ABSCESS 8 0.0018
461 TOXIC SKIN ERUPTION 18 0.0018
462 PNEUMONIA FUNGAL 7 0.0018
463 GENERAL PHYSICAL CONDITION ABNORMAL 12 0.0018
464 PRESYNCOPE 43 0.0018
465 PNEUMONIA ASPIRATION 44 0.0018
466 GRANULOCYTOPENIA 10 0.0018
467 ACUTE RESPIRATORY DISTRESS SYNDROME 31 0.0018
468 AUTOIMMUNE DISORDER 17 0.0017
469 RENAL DISORDER 81 0.0017
470 DIABETES MELLITUS 132 0.0017
471 PANCREATITIS 91 0.0017
472 UVEITIS 23 0.0017
473 SKIN INFECTION 19 0.0017
474 COLITIS MICROSCOPIC 8 0.0017
475 HEPATITIS FULMINANT 5 0.0017
476 RENAL IMPAIRMENT 141 0.0017
477 PULMONARY FIBROSIS 32 0.0017
478 ALTERED STATE OF CONSCIOUSNESS 36 0.0017
479 HYPERCAPNIA 5 0.0017
480 DERMATITIS BULLOUS 12 0.0017
481 HYPERPYREXIA 7 0.0017
482 EMBOLISM VENOUS 5 0.0016
483 TOXIC EPIDERMAL NECROLYSIS 25 0.0016
484 CARDIAC FAILURE 132 0.0016
485 THROMBOCYTOSIS 6 0.0016
486 ELECTROLYTE IMBALANCE 19 0.0016
487 VASCULITIS 19 0.0016
488 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
489 SHOCK 37 0.0016
490 RETINOPATHY 6 0.0016
491 WHITE BLOOD CELL COUNT DECREASED 173 0.0016
492 MYELODYSPLASTIC SYNDROME 23 0.0016
493 HYPOMAGNESAEMIA 22 0.0016
494 HYPONATRAEMIA 89 0.0016
495 PNEUMONIA 500 0.0015
496 GENERALISED OEDEMA 19 0.0015
497 LUNG NEOPLASM MALIGNANT 63 0.0015
498 BONE MARROW FAILURE 31 0.0015
499 ISCHAEMIA 7 0.0015
500 ARTERIOSPASM CORONARY 6 0.0015
501 HYPOVOLAEMIC SHOCK 7 0.0015
502 BACTERIAL INFECTION 27 0.0014
503 DECREASED APPETITE 336 0.0014
504 INFUSION SITE EXTRAVASATION 9 0.0014
505 ACUTE KIDNEY INJURY 220 0.0014
506 TASTE DISORDER 29 0.0014
507 DUODENAL ULCER 10 0.0014
508 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 33 0.0014
509 UROSEPSIS 13 0.0014
510 CARDIAC FAILURE CHRONIC 6 0.0014
511 PULMONARY OEDEMA 63 0.0014
512 HEPATIC ENZYME ABNORMAL 7 0.0014
513 C-REACTIVE PROTEIN INCREASED 51 0.0014
514 HYPERKALAEMIA 49 0.0014
515 EMPHYSEMA 14 0.0014
516 BLOOD ALBUMIN DECREASED 11 0.0014
517 HEPATITIS ACUTE 9 0.0014
518 ANKYLOSING SPONDYLITIS 18 0.0014
519 SHOCK HAEMORRHAGIC 11 0.0013
520 DIPLOPIA 35 0.0013
521 MALNUTRITION 15 0.0013
522 ESCHERICHIA INFECTION 11 0.0013
523 MUCOSAL INFLAMMATION 35 0.0013
524 IRON DEFICIENCY 6 0.0013
525 LEUKOCYTOSIS 24 0.0013
526 OPTIC NEURITIS 12 0.0013
527 NEUROTOXICITY 23 0.0013
528 EOSINOPHILIA 23 0.0013
529 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
530 GASTRIC HAEMORRHAGE 15 0.0013
531 TOXICITY TO VARIOUS AGENTS 219 0.0013
532 ATRIOVENTRICULAR BLOCK 10 0.0013
533 DEVICE OCCLUSION 18 0.0013
534 ASTHENIA 478 0.0013
535 PYELONEPHRITIS 11 0.0013
536 DEAFNESS 33 0.0013
537 INFLAMMATION 65 0.0013
538 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
539 HEPATIC CANCER 30 0.0012
540 ACUTE MYOCARDIAL INFARCTION 36 0.0012
541 HYPERCALCAEMIA 15 0.0012
542 GASTRIC ULCER 23 0.0012
543 PULMONARY EMBOLISM 115 0.0012
544 AORTIC DISSECTION 5 0.0012
545 INFUSION RELATED REACTION 80 0.0012
546 HYDRONEPHROSIS 9 0.0012
547 ATRIAL FIBRILLATION 117 0.0012
548 DEEP VEIN THROMBOSIS 78 0.0012
549 EOSINOPHIL COUNT INCREASED 10 0.0012
550 HEPATOCELLULAR INJURY 17 0.0012
551 ASPIRATION 13 0.0012
552 ACIDOSIS 9 0.0012
553 DRUG RESISTANCE 30 0.0012
554 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
555 PSEUDOMONAS INFECTION 10 0.0012
556 ACUTE MYELOID LEUKAEMIA 18 0.0012
557 ARTHRITIS 90 0.0011
558 INTESTINAL OBSTRUCTION 43 0.0011
559 FULL BLOOD COUNT ABNORMAL 12 0.0011
560 PIGMENTATION DISORDER 7 0.0011
561 LYMPHADENOPATHY 40 0.0011
562 HYPOKALAEMIA 52 0.0011
563 SENSORY LOSS 9 0.0011
564 ASPHYXIA 9 0.0011
565 LIVER INJURY 27 0.0011
566 EJECTION FRACTION DECREASED 17 0.0011
567 PHOTOSENSITIVITY REACTION 18 0.0011
568 DIARRHOEA 700 0.0011
569 HYPOPHOSPHATAEMIA 8 0.0011
570 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
571 INFECTION 155 0.0011
572 ANGIOPATHY 6 0.0011
573 OEDEMA 58 0.0011
574 OXYGEN SATURATION DECREASED 60 0.0011
575 GASTRITIS 28 0.0011
576 PERITONITIS 22 0.0011
577 REBOUND EFFECT 12 0.0011
578 APPETITE DISORDER 7 0.0011
579 RASH 460 0.0011
580 RESPIRATORY DISTRESS 29 0.0010
581 BLOOD CREATININE INCREASED 68 0.0010
582 MUSCULAR WEAKNESS 118 0.0010
583 RALES 6 0.0010
584 HYPOVOLAEMIA 6 0.0010
585 THROMBOSIS 82 0.0010
586 GAIT INABILITY 34 0.0010
587 GASTROINTESTINAL DISORDER 91 0.0010
588 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
589 HYPERVOLAEMIA 5 0.0010
590 DYSPNOEA EXERTIONAL 38 0.0010
591 DELIRIUM 35 0.0010
592 BLOOD SODIUM DECREASED 19 0.0010
593 SKIN ULCER 26 0.0010
594 STOMATITIS 61 0.0010
595 DEHYDRATION 134 0.0010
596 NEOPLASM MALIGNANT 67 0.0010
597 ATRIAL FLUTTER 8 0.0010
598 ANAL INCONTINENCE 9 0.0010
599 FLUID INTAKE REDUCED 5 0.0010
600 HEPATITIS CHOLESTATIC 6 0.0010
601 CORONARY ARTERY STENOSIS 5 0.0010
602 NEUTROPHIL COUNT INCREASED 10 0.0010
603 SPINAL COMPRESSION FRACTURE 8 0.0010
604 MYOCARDIAL ISCHAEMIA 11 0.0010
605 RESPIRATORY TRACT INFECTION 25 0.0010
606 GASTROENTERITIS 14 0.0010
607 DYSPHAGIA 91 0.0010
608 ORAL DISORDER 7 0.0010
609 ACUTE HEPATIC FAILURE 13 0.0010
610 BLOOD LACTIC ACID INCREASED 5 0.0009
611 CEREBRAL DISORDER 7 0.0009
612 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
613 HEMIPARESIS 16 0.0009
614 BLOOD MAGNESIUM DECREASED 8 0.0009
615 CHEILITIS 5 0.0009
616 HERPES SIMPLEX 6 0.0009
617 SKIN REACTION 13 0.0009
618 AORTIC ANEURYSM 7 0.0009
619 WRIST FRACTURE 11 0.0009
620 HAEMOGLOBIN DECREASED 94 0.0009
621 URINE OUTPUT DECREASED 8 0.0009
622 PARALYSIS 13 0.0009
623 RESPIRATORY DISORDER 27 0.0009
624 CYTOMEGALOVIRUS INFECTION 15 0.0009
625 HYPOPHAGIA 23 0.0009
626 SPINAL FRACTURE 18 0.0009
627 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
628 ELECTROCARDIOGRAM ABNORMAL 7 0.0009
629 ACUTE PULMONARY OEDEMA 5 0.0009
630 CARDIO-RESPIRATORY ARREST 37 0.0009
631 RENAL FAILURE 117 0.0009
632 ECCHYMOSIS 6 0.0009
633 DYSPNOEA 495 0.0009
634 IRON DEFICIENCY ANAEMIA 8 0.0009
635 NERVOUS SYSTEM DISORDER 27 0.0009
636 MUSCLE DISORDER 7 0.0009
637 TRANSFUSION 9 0.0009
638 PRODUCTIVE COUGH 41 0.0009
639 RIGHT VENTRICULAR FAILURE 6 0.0009
640 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
641 ANAPHYLACTIC SHOCK 22 0.0009
642 LYMPHOPENIA 12 0.0008
643 FRACTURE 16 0.0008
644 DEVICE RELATED INFECTION 13 0.0008
645 SECOND PRIMARY MALIGNANCY 7 0.0008
646 CHILLS 98 0.0008
647 PULMONARY CONGESTION 11 0.0008
648 HAEMATEMESIS 21 0.0008
649 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
650 ARRHYTHMIA 39 0.0008
651 DERMATITIS ACNEIFORM 5 0.0008
652 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
653 MOUTH HAEMORRHAGE 6 0.0008
654 GASTROINTESTINAL PAIN 9 0.0008
655 CARDIAC ARREST 67 0.0008
656 MOVEMENT DISORDER 26 0.0008
657 COLON CANCER 12 0.0008
658 CEREBROVASCULAR ACCIDENT 136 0.0008
659 HERPES ZOSTER 46 0.0008
660 COUGH 221 0.0008
661 ISCHAEMIC STROKE 14 0.0008
662 CEREBRAL HAEMORRHAGE 28 0.0008
663 COAGULOPATHY 13 0.0008
664 CARDIOGENIC SHOCK 11 0.0008
665 NODULE 10 0.0008
666 BEDRIDDEN 10 0.0008
667 RENAL CYST 6 0.0008
668 BREAST MASS 5 0.0007
669 BRONCHIECTASIS 5 0.0007
670 ANAPHYLACTIC REACTION 41 0.0007
671 COLITIS ISCHAEMIC 5 0.0007
672 PULMONARY THROMBOSIS 8 0.0007
673 HEPATIC ENZYME INCREASED 50 0.0007
674 ANGINA PECTORIS 21 0.0007
675 LIVER FUNCTION TEST ABNORMAL 21 0.0007
676 RHABDOMYOLYSIS 30 0.0007
677 METABOLIC ACIDOSIS 23 0.0007
678 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
679 SECRETION DISCHARGE 9 0.0007
680 RENAL TUBULAR NECROSIS 7 0.0007
681 CONSTIPATION 155 0.0007
682 CANDIDA INFECTION 12 0.0007
683 URINARY INCONTINENCE 21 0.0007
684 LUNG INFECTION 11 0.0007
685 OFF LABEL USE 616 0.0007
686 BRONCHOSPASM 10 0.0007
687 ANURIA 6 0.0007
688 ABDOMINAL PAIN 160 0.0007
689 HYPOCALCAEMIA 13 0.0007
690 DYSPHONIA 40 0.0007
691 GASTROINTESTINAL HAEMORRHAGE 57 0.0007
692 IMMUNOSUPPRESSION 6 0.0007
693 PURPURA 6 0.0007
694 DUODENAL ULCER PERFORATION 5 0.0007
695 HAEMORRHAGE INTRACRANIAL 10 0.0007
696 VENTRICULAR TACHYCARDIA 11 0.0007
697 DRY MOUTH 54 0.0007
698 MOUTH ULCERATION 14 0.0007
699 VOMITING 311 0.0007
700 HAEMODYNAMIC INSTABILITY 5 0.0007
701 HYPERTHERMIA 5 0.0007
702 COMA 31 0.0007
703 NERVE COMPRESSION 6 0.0006
704 HAEMOLYSIS 5 0.0006
705 BLOOD PRESSURE DECREASED 43 0.0006
706 FULL BLOOD COUNT DECREASED 13 0.0006
707 APHONIA 9 0.0006
708 GASTROINTESTINAL INFLAMMATION 5 0.0006
709 SQUAMOUS CELL CARCINOMA 6 0.0006
710 MELAENA 14 0.0006
711 SPINAL DISORDER 6 0.0006
712 COVID-19 111 0.0006
713 ORTHOSTATIC HYPOTENSION 11 0.0006
714 PULMONARY HYPERTENSION 13 0.0006
715 PANCREATIC CARCINOMA 18 0.0006
716 BLOOD CALCIUM DECREASED 7 0.0006
717 FATIGUE 484 0.0006
718 FRUSTRATION TOLERANCE DECREASED 5 0.0006
719 DYSSTASIA 18 0.0006
720 THIRST 11 0.0006
721 INTERNAL HAEMORRHAGE 7 0.0006
722 HAEMORRHAGE 64 0.0006
723 HEPATOMEGALY 6 0.0006
724 HEMIPLEGIA 5 0.0006
725 BLOOD POTASSIUM DECREASED 18 0.0006
726 SPLENOMEGALY 7 0.0006
727 PRODUCT PRESCRIBING ISSUE 13 0.0006
728 QUALITY OF LIFE DECREASED 8 0.0006
729 MYOCARDIAL INFARCTION 104 0.0006
730 WEIGHT DECREASED 166 0.0006
731 HYPOTENSION 118 0.0006
732 IMPAIRED GASTRIC EMPTYING 8 0.0006
733 COLITIS ULCERATIVE 26 0.0006
734 PETECHIAE 6 0.0006
735 OEDEMA PERIPHERAL 70 0.0006
736 OESOPHAGEAL CARCINOMA 17 0.0006
737 MASS 8 0.0006
738 URINARY RETENTION 19 0.0006
739 INCONTINENCE 6 0.0006
740 UPPER RESPIRATORY TRACT INFECTION 26 0.0006
741 HYPERTENSION 119 0.0006
742 GASTROINTESTINAL INFECTION 5 0.0006
743 URINARY TRACT INFECTION 95 0.0006
744 EPILEPSY 17 0.0006
745 BLOOD POTASSIUM INCREASED 9 0.0006
746 MYALGIA 94 0.0006
747 HYPOKINESIA 8 0.0006
748 DRUG INTOLERANCE 53 0.0005
749 CARDIAC DISORDER 51 0.0005
750 MALAISE 237 0.0005
751 VENTRICULAR FIBRILLATION 6 0.0005
752 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
753 CONJUNCTIVITIS 10 0.0005
754 FEELING COLD 15 0.0005
755 RHEUMATOID ARTHRITIS 61 0.0005
756 ECZEMA 28 0.0005
757 FLANK PAIN 5 0.0005
758 ORAL CANDIDIASIS 7 0.0005
759 SARS-COV-2 TEST POSITIVE 7 0.0005
760 ADVERSE REACTION 7 0.0005
761 PRURITUS 202 0.0005
762 HAEMATURIA 18 0.0005
763 HYPERSOMNIA 15 0.0005
764 WHEEZING 31 0.0005
765 DIZZINESS POSTURAL 5 0.0005
766 STAPHYLOCOCCAL INFECTION 17 0.0005
767 GINGIVAL BLEEDING 7 0.0005
768 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
769 LYMPHOCYTE COUNT DECREASED 9 0.0005
770 ULCER 8 0.0005
771 BLOOD TEST ABNORMAL 7 0.0005
772 RASH PRURITIC 27 0.0005
773 BODY TEMPERATURE INCREASED 10 0.0005
774 RED BLOOD CELL COUNT DECREASED 14 0.0005
775 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
776 BLOOD GLUCOSE ABNORMAL 9 0.0005
777 INJECTION SITE EXTRAVASATION 6 0.0005
778 HEPATIC STEATOSIS 9 0.0005
779 PEMPHIGUS 6 0.0005
780 TACHYCARDIA 42 0.0005
781 CARDIOVASCULAR DISORDER 12 0.0005
782 EATING DISORDER 10 0.0005
783 WHITE BLOOD CELL COUNT INCREASED 18 0.0005
784 NAUSEA 371 0.0005
785 CONFUSIONAL STATE 75 0.0005
786 HIATUS HERNIA 6 0.0005
787 DISCOMFORT 28 0.0005
788 CELLULITIS 23 0.0005
789 LYMPHOMA 7 0.0005
790 MOBILITY DECREASED 32 0.0004
791 CYANOSIS 7 0.0004
792 DISEASE RECURRENCE 21 0.0004
793 LABORATORY TEST ABNORMAL 13 0.0004
794 RASH ERYTHEMATOUS 21 0.0004
795 ALOPECIA 86 0.0004
796 RENAL INJURY 13 0.0004
797 HYPOGLYCAEMIA 21 0.0004
798 APHASIA 13 0.0004
799 CONDITION AGGRAVATED 130 0.0004
800 BLISTER 24 0.0004
801 EYE DISORDER 14 0.0004
802 CHEST PAIN 78 0.0004
803 VIRAL INFECTION 14 0.0004
804 MUSCULOSKELETAL DISORDER 8 0.0004
805 HAEMATOCHEZIA 23 0.0004
806 POST PROCEDURAL COMPLICATION 8 0.0004
807 LOWER LIMB FRACTURE 8 0.0004
808 FAECES DISCOLOURED 9 0.0004
809 HEPATITIS C 5 0.0004
810 PSORIASIS 54 0.0004
811 BURSITIS 5 0.0004
812 NEURALGIA 10 0.0004
813 PERIPHERAL SWELLING 63 0.0004
814 KIDNEY INFECTION 8 0.0004
815 HIP FRACTURE 13 0.0004
816 DISORIENTATION 16 0.0004
817 ARTHRALGIA 167 0.0004
818 SYNCOPE 40 0.0004
819 HEART RATE IRREGULAR 9 0.0004
820 SEIZURE 46 0.0004
821 DERMATITIS ALLERGIC 5 0.0004
822 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
823 MENTAL STATUS CHANGES 11 0.0004
824 GASTRIC CANCER 10 0.0004
825 ABDOMINAL DISTENSION 41 0.0004
826 INSURANCE ISSUE 6 0.0004
827 LOSS OF CONSCIOUSNESS 50 0.0004
828 GOUT 7 0.0004
829 THERAPY CESSATION 20 0.0004
830 MUSCULOSKELETAL CHEST PAIN 6 0.0004
831 TENDONITIS 6 0.0004
832 HYPOAESTHESIA 58 0.0004
833 TYPE 2 DIABETES MELLITUS 13 0.0004
834 BACK PAIN 89 0.0004
835 ABSCESS 6 0.0004
836 FLUID RETENTION 19 0.0004
837 HYPOACUSIS 16 0.0004
838 LACTIC ACIDOSIS 12 0.0004
839 ILLNESS 38 0.0004
840 BLINDNESS 15 0.0004
841 RESPIRATORY ARREST 10 0.0004
842 HERNIA 7 0.0004
843 AGEUSIA 9 0.0004
844 NECK PAIN 20 0.0004
845 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
846 CIRCULATORY COLLAPSE 6 0.0004
847 GAIT DISTURBANCE 66 0.0003
848 SPEECH DISORDER 18 0.0003
849 CHOLELITHIASIS 11 0.0003
850 THROAT TIGHTNESS 9 0.0003
851 OSTEOMYELITIS 6 0.0003
852 LETHARGY 19 0.0003
853 CORONARY ARTERY DISEASE 10 0.0003
854 FUNGAL INFECTION 11 0.0003
855 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
856 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
857 DIVERTICULITIS 9 0.0003
858 BRONCHITIS 24 0.0003
859 PRODUCT DOSE OMISSION 21 0.0003
860 BASAL CELL CARCINOMA 5 0.0003
861 CATARACT 19 0.0003
862 CHEST DISCOMFORT 32 0.0003
863 NO ADVERSE EVENT 56 0.0003
864 EAR PAIN 6 0.0003
865 ADVERSE EVENT 28 0.0003
866 RECTAL HAEMORRHAGE 13 0.0003
867 MENTAL DISORDER 13 0.0003
868 FACE OEDEMA 5 0.0003
869 EYE SWELLING 11 0.0003
870 PSORIATIC ARTHROPATHY 12 0.0003
871 PRODUCT USE IN UNAPPROVED INDICATION 73 0.0003
872 FALL 98 0.0003
873 PARAESTHESIA 46 0.0003
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
875 ABDOMINAL PAIN UPPER 60 0.0003
876 BONE PAIN 17 0.0003
877 PROCEDURAL PAIN 8 0.0003
878 TINNITUS 13 0.0003
879 HEAD DISCOMFORT 5 0.0003
880 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
881 EPISTAXIS 21 0.0003
882 NIGHT SWEATS 9 0.0003
883 ABDOMINAL PAIN LOWER 7 0.0003
884 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
885 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
886 WEIGHT INCREASED 61 0.0003
887 ORAL PAIN 6 0.0003
888 MUSCULOSKELETAL PAIN 14 0.0003
889 THERAPY NON-RESPONDER 12 0.0003
890 VISUAL IMPAIRMENT 33 0.0003
891 DYSARTHRIA 10 0.0003
892 BRADYCARDIA 14 0.0003
893 VERTIGO 16 0.0003
894 HYPERSENSITIVITY 48 0.0003
895 COGNITIVE DISORDER 12 0.0003
896 SKIN LESION 7 0.0003
897 DIZZINESS 127 0.0003
898 DYSPEPSIA 25 0.0003
899 BLOOD PRESSURE ABNORMAL 5 0.0003
900 CYSTITIS 8 0.0003
901 CARDIAC FAILURE CONGESTIVE 20 0.0002
902 BLOOD PRESSURE INCREASED 38 0.0002
903 LOCALISED INFECTION 6 0.0002
904 ILL-DEFINED DISORDER 15 0.0002
905 RESTLESSNESS 9 0.0002
906 SWELLING FACE 16 0.0002
907 ADVERSE DRUG REACTION 22 0.0002
908 DYSURIA 9 0.0002
909 PAIN 150 0.0002
910 OSTEOPOROSIS 10 0.0002
911 HEART RATE INCREASED 24 0.0002
912 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 43 0.0002
913 OSTEOARTHRITIS 10 0.0002
914 UNRESPONSIVE TO STIMULI 6 0.0002
915 DRUG INEFFECTIVE 296 0.0002
916 CHROMATURIA 5 0.0002
917 LIMB INJURY 6 0.0002
918 URTICARIA 37 0.0002
919 VISION BLURRED 30 0.0002
920 SKIN DISCOLOURATION 10 0.0002
921 TREMOR 36 0.0002
922 ARTHROPATHY 12 0.0002
923 MEDICATION ERROR 12 0.0002
924 AMNESIA 14 0.0002
925 SWELLING 20 0.0002
926 SLEEP DISORDER 15 0.0002
927 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
928 CHRONIC KIDNEY DISEASE 16 0.0002
929 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
930 INSOMNIA 56 0.0002
931 BALANCE DISORDER 18 0.0002
932 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
933 OROPHARYNGEAL PAIN 19 0.0002
934 HEART RATE DECREASED 7 0.0002
935 BLOOD GLUCOSE INCREASED 37 0.0002
936 MUSCULOSKELETAL STIFFNESS 17 0.0002
937 ERYTHEMA 39 0.0002
938 SOMNOLENCE 38 0.0002
939 DYSGEUSIA 14 0.0002
940 PAIN IN EXTREMITY 55 0.0002
941 NASOPHARYNGITIS 34 0.0002
942 IMPAIRED HEALING 6 0.0002
943 INFLUENZA LIKE ILLNESS 15 0.0002
944 ANGIOEDEMA 8 0.0002
945 INFLUENZA 20 0.0002
946 DEMENTIA 5 0.0002
947 HYPERHIDROSIS 23 0.0002
948 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
949 MEMORY IMPAIRMENT 24 0.0002
950 RASH MACULAR 6 0.0002
951 BLADDER CANCER 10 0.0002
952 ASTHMA 19 0.0002
953 THERAPY INTERRUPTED 12 0.0002
954 POLLAKIURIA 7 0.0002
955 FLUSHING 17 0.0002
956 SKIN EXFOLIATION 14 0.0002
957 PRODUCT DOSE OMISSION ISSUE 48 0.0002
958 FEMUR FRACTURE 5 0.0002
959 DRY EYE 8 0.0002
960 FEELING ABNORMAL 38 0.0002
961 HEADACHE 99 0.0002
962 PRODUCT USE ISSUE 29 0.0002
963 ABNORMAL BEHAVIOUR 6 0.0002
964 DEPRESSED MOOD 8 0.0002
965 JOINT SWELLING 18 0.0001
966 DISTURBANCE IN ATTENTION 8 0.0001
967 BLOOD GLUCOSE DECREASED 7 0.0001
968 PALPITATIONS 17 0.0001
969 ANXIETY 41 0.0001
970 DRY SKIN 19 0.0001
971 FLATULENCE 8 0.0001
972 DEPRESSION 32 0.0001
973 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
974 MUSCLE SPASMS 25 0.0001
975 ABDOMINAL DISCOMFORT 22 0.0001
976 NEPHROLITHIASIS 6 0.0001
977 SINUSITIS 13 0.0001
978 HALLUCINATION 9 0.0001
979 UNEVALUABLE EVENT 9 0.0001
980 IRRITABILITY 7 0.0001
981 UNDERDOSE 8 0.0001
982 RHINORRHOEA 7 0.0001
983 FEELING HOT 6 0.0001
984 HOSPITALISATION 15 0.0001
985 EYE PAIN 5 0.0001
986 DRUG INTERACTION 14 0.0001
987 PROSTATE CANCER 7 0.0001
988 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
989 CONTUSION 7 0.0001
990 BURNING SENSATION 5 0.0001
991 AGITATION 5 0.0001
992 ACNE 5 0.0001
993 BREAST CANCER 5 0.0001
994 OVERDOSE 9 0.0000
995 INCORRECT DOSE ADMINISTERED 6 0.0000